Detalhe da pesquisa
1.
Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial.
World J Urol
; 38(4): 1001-1007, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31177305
2.
Safety and long-term results of endoscopic transanal resection in treating rectal adenomas: 15 years' experience.
Surg Endosc
; 27(9): 3431-6, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23494510
3.
Awareness of Smoking as a Risk Factor in Bladder Cancer: Results from the Prospective FinnBladder 9 Trial.
Eur Urol Focus
; 8(5): 1246-1252, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094962
4.
Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study.
Eur Urol Oncol
; 1(6): 525-530, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158099
5.
Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study.
Eur Urol
; 70(2): 341-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27085624
6.
Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
Eur Urol
; 68(4): 611-7, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25748117
7.
Promoting Children's Health with Digital Games: A Review of Reviews.
Games Health J
; 3(3): 145-56, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26196173
8.
Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study--FinnBladder III long-term results.
J Urol
; 168(3): 981-5, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12187204
9.
Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma.
Eur Urol
; 42(2): 167-74, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12160589